21 reports

Global Market Study on Rare Endocrine Disease Treatment: Appropriate Treatment Evaluation and Research Collaborations to Drive Treatment Developments during 2017-2026 ##.

  • Endocrine Disease
  • Therapy
  • World
  • Market Shares
  • Market Size
  • Hypoparathyroidism - Product Development Milestones

Hypoparathyroidism is a rare endocrine disease resulting from an inappropriately low circulating PTH concentration.

  • Endocrine Disease
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Hypothyroidism Trial Snapshots- 2013
  • Hypothyroidism Trial Snapshots- 2013

Auto-immune diseases, thyroidectomy, radiotherapy, radioiodine thyroid ablation typically cause hypothyroidism.

  • Clinical Trial
  • Endocrine Disease
  • World
  • Company Operations
  • Product Initiative

This agreement enables PeptiDream and Ipsen to discover, develop and commercialize therapeutic peptides to treat serious Endocrine diseases.

  • Endocrine Disease
  • Pharmaceutical
  • Therapy
  • Demand
  • Ipsen S.A.

CLINICAL TRIALS BY PHASE IN G## COUNTRIES CARDIOMETABOLIC DISEASE THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* CARDIOMETABOLIC DISEASE THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* CARDIOMETABOLIC DISEASE THERAPEUTICS, G## COUNTRIES, CLINICAL TRI

  • Clinical Trial
  • Drug Development
  • Endocrine Disease
  • World
  • Product Initiative
  • MAR 12, 2018: SHIRE TO HIGHLIGHT ADVANCEMENTS IN CHRONIC HYPOPARATHYROIDISM RESEARCH AT THE ENDOCRINE SOCIETY'S 2018 ANNUAL MEETING
  • APR 26, 2017: SHIRE GRANTED EU CONDITIONAL MARKETING AUTHORISATION FOR NATPAR (PARATHYROID HORMONE) FOR THE TREATMENT OF PATIENTS WITH CHRONIC HYPOPARATHYROIDISM

MAR ##, 2018: NEW DATA PRESENTED AT THE ENDOCRINE SOCIETY' S 2018 ANNUAL MEETING ADVANCES UNDERSTANDING OF THE RARE DISEASE CHRONIC HYPOPARATHYROIDISM Shire plc, the global leader in rare diseases, announced new data on its recombinant human parathyroid hormone (

  • Endocrine Disease
  • Europe
  • United States
  • World
  • Product Initiative
  • Hypothyroidism - Companies Involved in Therapeutics Development
  • Hypothyroidism - Pipeline by Diurnal Group Plc, H2 2018

The molecules developed by Companies in Phase III, Preclinical and Unknown stages are ##, ## and ## respectively.

  • Endocrine Disease
  • Hormone
  • Therapy
  • World
  • Product Initiative
  • 06/21/2018: Crinetics Pharmaceuticals Awarded up to $3.2 Million in SBIR Grants for Acromegaly

Poster Presentations: Oct ##, 2017: Crinetics Pharmaceuticals Initiates Phase ## Study of Lead Candidate CRN## for Acromegaly Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, annou

  • Endocrine Disease
  • Pharmaceutical
  • United States
  • Company
  • Crinetics Pharmaceuticals, Inc.
  • Hypothyroidism - Companies Involved in Therapeutics Development
  • Hypothyroidism - Pipeline by Synthonics Inc, H1 2018

Risk factors include autoimmune diseases, thyroid surgery, radiation therapy and family history of thyroid disease.

  • Endocrine Disease
  • Hormone
  • Therapy
  • World
  • Product Initiative

The report includes coverage of disease clinical trials by region and top countries, trial phase, trial status, end points status and sponsor type.

  • Endocrine Disease
  • Pathology
  • Therapy
  • World
  • Product Initiative
  • Hyperthyroidism Trial Snapshots- 2012

One trial entered phase ##.

  • Drug Development
  • Endocrine Disease
  • World
  • Company Operations
  • Product Initiative
  • 06/21/2018: Crinetics Pharmaceuticals Awarded up to $3.2 Million in SBIR Grants for Acromegaly

Poster Presentations: Oct ##, 2017: Crinetics Pharmaceuticals Initiates Phase ## Study of Lead Candidate CRN## for Acromegaly Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, annou

  • Endocrine Disease
  • Pharmaceutical
  • United States
  • Company
  • Crinetics Pharmaceuticals, Inc.

Four patients had gastrinoma, and ## of them had multiple endocrine neoplasia type ##.

  • Endocrine Disease
  • Therapy
  • United States
  • World
  • Product Initiative

The company' s submission of abemaciclib includes two indications: abemaciclib monotherapy for patients with hormone-receptor-positive (HR+), human epidermal growth factor receptor ##-negative (HER##-) advanced breast cancer who had prior endocrine therapy and chemotherapy for metastatic

  • Clinical Trial
  • Endocrine Disease
  • Insulin Delivery
  • Pharmaceutical
  • Sanofi S.A.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

CARDIOMETABOLIC DISEASE THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2017* CARDIOMETABOLIC DISEASE THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2017* CARDIOMETABOLIC DISEASE THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, ##

  • Endocrine Disease
  • Medical Biotechnology
  • Pathology
  • World
  • Product Initiative

Radius Health, Inc., a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics in the areas of osteoporosis and oncology, presented results from " Response Rates for Hip, Femoral Neck, and Lumbar Spi

  • Endocrine Disease
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • World
  • 2.1 DISEASE BACKGROUND

Endocrine Connections; ##(##): ##-##.

  • Endocrine Disease
  • Japan
  • United Kingdom
  • United States
  • Forecast

Radius Health, Inc., a science-driven biopharmaceutical company that is committed to developing innovative therapeutics in the areas of osteoporosis, oncology and endocrine diseases, announced that additional positive results from the Phase ## ACTIVE (Abaloparatide Comparator Trial

  • Clinical Trial
  • Endocrine Disease
  • Pharmaceutical
  • Therapy
  • World

ENDOCRINE HORMONES: THE PRODUCTS SECRETED BY THE ENDOCRINE GLANDS.

  • Endocrine Disease
  • United States
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Takeda Pharmaceutical Company Limited
  • 4.1 DISEASE BACKGROUND

ENDOCRINE PRACTICE; ##(##): ##-##.

  • Endocrine Disease
  • Forecast
  • Amgen Inc.
  • Keryx Biopharmaceuticals, Inc.
  • OPKO Health, Inc.
  • XOMA Corporation - Company Statement

Our business efforts are focused on advancing the assets in our portfolio of compounds that could treat a variety of endocrine diseases.

  • Endocrine Disease
  • Therapy
  • United States
  • Company Operations
  • XOMA Corporation